Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals

AIDS. 2008 Mar 12;22(5):595-9. doi: 10.1097/QAD.0b013e3282f56b23.

Abstract

Objectives: Natural killer (NK) cell activity is increased in individuals who remain uninfected despite repeated exposures to HIV. Given that a combined major histocompatibility complex (MHC) class I and killer immunoglobulin-like receptor (KIR) KIR3D genotype has been linked to rate of HIV disease progression, we assessed whether these genotypes played a role in protection from infection.

Design: The study genotyped 80 HIV-exposed uninfected (EU) and 304 subjects in HIV primary infection (PI) at the MHC class IB and KIR3DS/L1 loci.

Methods: KIR3D genotyping was performed by sequence-specific primer polymerase chain reaction using two pairs of specific primers for each locus. The MHC class IB locus was typed by sequence-specific oligonucleotide polymerase chain reaction and sequencing to resolve Bw4 and Bw6 alleles and the amino acid present at position 80.

Results: Comparison of the genetic distribution of KIR3D, HLA Bw4 and HLA Bw4-I80 genotypes in EU versus PI subjects reveal an increased proportion of KIR3DS1 homozygotes in EU (11/80, 13.8%) compared to subjects in PI (16/304, 5.3%). Analyses of combined MHC class I and KIR3D expression show no differences between the two populations.

Conclusions: Homozygosity for the activating NK receptor KIR3DS1, may contribute to the more active NK cell function observed in EU and their relative resistance to HIV infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Case-Control Studies
  • Chi-Square Distribution
  • Disease Progression
  • Female
  • Genes, MHC Class I*
  • Genotype
  • HIV Infections / genetics
  • HIV Infections / immunology*
  • HIV Seronegativity / genetics
  • HIV Seronegativity / immunology*
  • HLA-B Antigens / genetics
  • Homozygote
  • Humans
  • Killer Cells, Natural / metabolism*
  • Male
  • Prospective Studies
  • Receptors, KIR3DS1 / genetics*
  • Sample Size

Substances

  • HLA-B Antigens
  • HLA-Bw4 antigen
  • HLA-Bw6 antigen
  • Receptors, KIR3DS1